These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34928388)

  • 1. Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Syndrome: A Longitudinal Study.
    Lee I; Vresilovic J; Irfan M; Gallop R; Dokras A
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1558-e1567. PubMed ID: 34928388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected].
    Hillman JK; Johnson LN; Limaye M; Feldman RA; Sammel M; Dokras A
    Fertil Steril; 2014 Feb; 101(2):530-5. PubMed ID: 24382375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression, Anxiety, and Risk of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Longitudinal Study.
    Lee IT; Rees J; King S; Kim A; Cherlin T; Hinkle S; Mumford SL; Dokras A
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38609160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study.
    Behboudi-Gandevani S; Ramezani Tehrani F; Hosseinpanah F; Khalili D; Cheraghi L; Kazemijaliseh H; Azizi F
    Fertil Steril; 2018 Dec; 110(7):1377-1386. PubMed ID: 30503137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the Childhood Determinants of Adult Health Study and the Bogalusa Heart Study.
    He Y; Tian J; Blizzard L; Oddy WH; Dwyer T; Bazzano LA; Hickey M; Harville EW; Venn AJ
    Hum Reprod; 2020 May; 35(5):1185-1198. PubMed ID: 32344436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Predictors of Hypertension in a Cohort of Australian Women With and Without Polycystic Ovary Syndrome.
    Joham AE; Kakoly NS; Teede HJ; Earnest A
    J Clin Endocrinol Metab; 2021 May; 106(6):1585-1593. PubMed ID: 33693653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
    Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
    Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
    Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Variation in Hormonal and Metabolic Parameters of White and Black Women With PCOS in the United States.
    VanHise K; Chan JL; Wertheimer S; Handelsman RG; Clark E; Buttle R; Wang ET; Azziz R; Pisarska MD
    J Clin Endocrinol Metab; 2023 Feb; 108(3):706-712. PubMed ID: 36218376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic Ovary Syndrome Signs and Metabolic Syndrome in Premenopausal Hispanic/Latina Women: the HCHS/SOL Study.
    Meyer ML; Sotres-Alvarez D; Steiner AZ; Cousins L; Talavera GA; Cai J; Daviglus ML; Loehr LR
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e447-56. PubMed ID: 31917455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years.
    Fernandez RC; Moore VM; Rumbold AR; Whitrow MJ; Avery JC; Davies MJ
    Hum Reprod; 2021 Jul; 36(8):2275-2284. PubMed ID: 33963388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor From Jialal: "Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Syndrome: A Longitudinal Study".
    Jialal I
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2198-e2199. PubMed ID: 34979022
    [No Abstract]   [Full Text] [Related]  

  • 17. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome.
    Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Poromaa IS
    Fertil Steril; 2021 Sep; 116(3):862-871. PubMed ID: 34053678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.
    Welt CK; Arason G; Gudmundsson JA; Adams J; Palsdóttir H; Gudlaugsdóttir G; Ingadóttir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4361-8. PubMed ID: 16940441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study.
    Ladson G; Dodson WC; Sweet SD; Archibong AE; Kunselman AR; Demers LM; Williams NI; Coney P; Legro RS
    Fertil Steril; 2011 Jul; 96(1):224-229.e2. PubMed ID: 21723443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Kazemi M; Kim JY; Parry SA; Azziz R; Lujan ME
    Am J Obstet Gynecol; 2021 May; 224(5):428-444.e8. PubMed ID: 33316275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.